URDANETA CITY

UNIVERSITY COLLEGE OF HEALTH SCIENCES

Owned and operated by the City Government of Urdaneta

DRUG STUDY
Name of Student: GALIT, SUFINA ANN ALZATE Year Level and Group: BSN-3 GROUP A

Affiliating Agency/Area: Month/Year of Exposure: NOVEMBER 2021

DRUG CLASSIFICATION INDICATION SIDE EFFECTS ADVERSE EFFECTS NURSING RESPONSIBILITIES

Generic Name: Assessment & Drug Effects:

ALBUTEROL Adrenergic Broncodilators Albuterol sulfate inhalation  Tremor  Irregular heartbeat  Monitor therapeutic effectiveness which is indicated
INHALATION solution is indicated for the by significant subjective improvement in pulmonary
Nausea Chest pain
relief of bronchospasm in function within 60–90 min after drug administration.
 

Brand Name:
patients 2 years of age and Nervousness Rash
Consult physician about giving last albuterol dose
 

older with reversible


PROVENTIL HFA
Headache Hives several hours before bedtime, if drug-induced
obstructive airway disease  

Dosage: insomnia is a problem.

and acute attacks of
 Cough  Itching
bronchospasm. Monitor for: S&S of fine tremor in fingers, which may
1-2 INHALATIONS 

 Throat irritation  Swelling of the face, interfere with precision handwork; CNS stimulation,
Route: throat, tongue, lips, particularly in children 2–6 y, (hyperactivity,
vomiting
eyes, hands, feet,

excitement, nervousness, insomnia), tachycardia, GI
INHALATION
 Muscle, bone or back ankles or lower legs symptoms. Report promptly to physician.
Frequency: pain
 Increased difficulty of
q4-6h breathing
Lab tests:
 Diffiulty swallowing
 Periodic ABGs, pulmonary functions, and pulse
oximetry.

Patient & Family Education:

 Review directions for correct use of medication and

inhaler

(075) 600 - 1507

Bright future starts here San Vicente West, Urdaneta City, Pangasinan
ucu.edu.ph | ucu.collegeofhealthsciences@gmail.com
 URDANETA CITY
UNIVERSITY
Owned and operated by the City Government of Urdaneta
MECHANISM OF ACTION
Albuterol acts on beta-2
adrenergic receptors to
relax the bronchial smooth
muscle. It also inhibits the
release of immediate
hypersensitivity
mediators from cells,
especially mast cells.
Although albuterol also
affects beta-1 adrenergic
receptors, this is minimal
and has little effect on the
heart rate.
Checked by: MRS. JOANN BANIAGO Date:
Clinical Instructor’s Name and Signature
Bright future starts here
CONTRAINDICATIONS
Albuterol sulfate inhalation
solution is contraindicated
in patients with a history of
hypersensitivity to any of its
components.
COLLEGE OF HEALTH SCIENCES
 Avoid contact of inhalation drug with eyes.
 Do not increase number or frequency of inhalations
without advice of physician.
Notify physician if albuterol fails to provide relief

because this can signify worsening of pulmonary
function and a reevaluation of condition/therapy may
be indicated.
 Note: Albuterol can cause dizziness or vertigo; take
necessary precautions.
 Do not use OTC drugs without physician approval.
Many medications (e.g., cold remedies) contain drugs
that may intensify albuterol action.
(075) 600 - 1507
San Vicente West, Urdaneta City, Pangasinan
ucu.edu.ph | ucu.collegeofhealthsciences@gmail.com
 URDANETA CITY
UNIVERSITY COLLEGE OF HEALTH SCIENCES
Owned and operated by the City Government of Urdaneta

DRUG STUDY
Name of Student: GALIT, SUFINA ANN ALZATE Year Level and Group: BSN-3 GROUP A

Affiliating Agency/Area: Month/Year of Exposure: NOVEMBER 2021

DRUG CLASSIFICATION INDICATION SIDE EFFECTS ADVERSE EFFECTS NURSING RESPONSIBILITIES

Generic Name: Assessment & Drug Effects:

BUDESONIDE Corticosteroids Budesonide is indicated for  Belching  Nasopharyngitis Monitor for signs and symptoms of hypercorticism.
the treatment of mild to
Brand Name: Blemishes on the skin Nasalcongestion phary
moderate Crohn’s disease,
 

ngitis Monitor for signs and symptoms of adrenal insufficiency.

FORACORT INHALER maintenance of Remission  Heartburn
of miltd to moderate  Rhinitis
Dosage: Crohn’s disease, for treating Indigestion
Monitor adrenocortical function in patients transferring


bronchial asthma and Oral candidiasis

from corticosteroids with higher systemic effects.

180 mcg  Tiredness
COPD.
 Pneumonia
Route:  Pimples
 Adrenal insufficiency Monitor bone mineral content in patients at high risk of
ORAL INHALATION  Moon face decreased bone mineral density.
 Vomiting
Frequency:  Cough
 Abdominal pain Monitor growth regularly in pediatric patients.
B.I.D.

Regular eye examinations should be considered, especially

in patients with a history of ocular changes or those
experiencing visual changes.

Lab tests:

Periodic serum potassium.

(075) 600 - 1507

Bright future starts here San Vicente West, Urdaneta City, Pangasinan
ucu.edu.ph | ucu.collegeofhealthsciences@gmail.com
 URDANETA CITY
UNIVERSITY
Owned and operated by the City Government of Urdaneta
MECHANISM OF ACTION
Budesonide works by
preventing inflammation
(swelling) in the lungs,
which makes the asthma
attack less severe. Inhaled
budesonide may be used
with other asthma
medicines such as
bronchodilators, which are
also used to open up
narrowed breathing
passages in the lungs.
Bright future starts here
CONTRAINDICATIONS
Budesonide is
contraindicated for patients
with hypersensitivity to
budesonide or any
ingredients.
COLLEGE OF HEALTH SCIENCES
Patient & Family Education:
Patients should understand that this drug is a
corticosteroid; they should know the signs and symptoms
of hypercorticism and adrenal suppression.
Patients should understand that during times of stress,
such as surgery or infection, additional oral
supplementation may be necessary; they should discuss
with their healthcare professional whether they need to
carry a medical identification card identifying their
corticosteroid use.
Patients on immunosuppressant doses of corticosteroids
should understand that a greater risk of infection exists;
they should avoid exposure to chickenpox or measles and
if exposed, they should consult their healthcare
professional promptly.
Patients should avoid grapefruit juice during therapy and
should check with their healthcare provider before taking
any new medications, including herbal supplements and
over the counter products.
Patients should be instructed on proper inhaler technique
and the importance of regular use.
(075) 600 - 1507
San Vicente West, Urdaneta City, Pangasinan
ucu.edu.ph | ucu.collegeofhealthsciences@gmail.com
 URDANETA CITY
UNIVERSITY COLLEGE OF HEALTH SCIENCES
Owned and operated by the City Government of Urdaneta

Patients should understand this drug is not intended to

relieve acute asthma symptoms and a short acting
bronchodilator should be used for that; if asthma
symptoms do not respond to a short acting bronchodilator,
or require higher or more frequent dosing, they should
contact their healthcare professional for reevaluation of
therapy.

Patients should be instructed to rinse and spit after oral

inhalation use to avoid infection; if infection develops, they
should contact their healthcare professional.

Inform patients that rectal foam products may contain

propellants which are flammable; appropriate precautions
should be taken.

Checked by: MRS. JOANN BANIAGO Date:

Clinical Instructor’s Name and Signature

(075) 600 - 1507

Bright future starts here San Vicente West, Urdaneta City, Pangasinan
ucu.edu.ph | ucu.collegeofhealthsciences@gmail.com
 URDANETA CITY
UNIVERSITY COLLEGE OF HEALTH SCIENCES
Owned and operated by the City Government of Urdaneta

NURSING CARE PLAN (NCP)

Name of Student: GALIT, SUFINA ANN ALZATE Year Level and Group: BSN-3 GROUP A

Affiliating Agency/Area: Month/Year of Exposure: NOVEMBER 2021

Assessment Nursing Diagnosis Planning Intervention Rationale Evaluation

(at least 10)

Subjective: Problem, Etiology, Signs
(P.E.S.) format
“Dalawang linggo ng
inuubo ang anak ko, TOP PRIORITY: Ineffective
lumalala tuwing gabi. Airway Clearance related to
Mainit din siya sa increased amount of
tuwing inilalagay ko secretions in the airways a as
palad ko sa noo niya.” evidenced by rhonchi and
as verbalized by the occasional wheezes are
mother. heard.
ii. Activity Intolerance
iii. Deficient Knowledge
Short Term Goal:
S.M.A.R.T. + Evidence
After 8 hours of nursing
interventions, the patient will
maintain airway patency as
evidenced by patient’s
exhibits absence of
adventitious breath sounds
such as rhonchi and
wheezing.
Independent: Short Term Goal Evaluation:
 Assessment
1. Assess respiratory rate, depth, 1. Changes in the respiratory rate
and rhythm. and rhythm may indicate an early PARTIALLY MET. After 8 hours of
nursing interventions, the patient
sign of impending respiratory
2. Auscultate lungs for shalll maintain airway patency as
distress.
adventitious breath sounds evidenced by patient’s exhibits
absence of adventitious breath
(wheezes and rhonchi). 2. Wheezes suggest partial
sounds such as rhonchi and wheezing.
obstruction or resistance. While
3. Assess the effectiveness of rhonchi may indicate retained
cough.
secretions in the lungs.
 Therapeutic 3. Coughing is a natural way to

(075) 600 - 1507

Bright future starts here San Vicente West, Urdaneta City, Pangasinan
ucu.edu.ph | ucu.collegeofhealthsciences@gmail.com
 URDANETA CITY
UNIVERSITY COLLEGE OF HEALTH SCIENCES
Owned and operated by the City Government of Urdaneta

Objective: INFERENCE Long Term Goal: 4. Pace the client’s activities. clear the throat and breathing Long Term Goal Evaluation:
(at least 5) Scientific Explanation (Diagram S.M.A.R.T.+ Evidence
passage of foreign particles,
Form) 5. Assist patient to assume to After 3 days of nursing interventions,
Cough After 3 days of nursing irritants, and mucus. the patient’s knowledge shall
comfortable position such as


 Alert and TRIGGER FACTOR interventions, the patient’s increased about the causes and
cooperative in knowledge will increased elevation of head. 4. Break up activities into smaller
control of allergic symptoms as
minimal distress
about the causes and control parts and take rest breaks in evidence by able to state the
Eyes are clear ALLERGIC SENSITIZATION  Educative

of allergic symptoms as between to avoid fatigue. methods of avoding allergens and
 Nasal mucosa is 6. Instruct to avoid exposure to
boggy with clear evidence by able to state the increased effort in breathing controlling indoor and outdoor
methods of avoding allergens persons with respiratory
discharge AIRWAY INFLAMMATION properly. precipitating factors.
 Pharynx has and controlling indoor and infections, how to cover
moderate lymphoid outdoor precipitating factors. mouth and nose when 5. Elevation of head of the bed
hypertrophy ALLERGY S&S coughing or sneezing, and to
Multiple lymph
facilitates respiratory function by
dispose of tissues.


nodes palpable in use of gravity.

upper neck SNEEZING, NASAL CONGESTION,
 Increase AP ITCHY OR RUNNY NOSE, SKIN
Dependent: 6. Prevents transmission
 Assessment
diameter REACTION, COUGH of microorganisms by
Tympanitic to 7. Monitor side effects of


percussion
airborne droplets.
bronchodilator.
Rhonchi and AFFECTS LUNGS AND AIRWAYS
7. Anticholinergic medications


occasional wheezes  Therapeutic

are heard on 8. Obtain peak expiratory flow are the first line drugs for client
auscultation but no INCEPTION OF ASTHMA
rate (PEFR) or forced with this condition.
retractions
 Heart is in regular expiratory volume in 1 second 8. Peak expiratory flow rate
rhythm and no (FEV1) before and after
murmurs
(PEFR) is the maximum flow rate
 Skin is dry, but not respiratory treatment, as generated during forceful
flaky, inflamed or indicated. exhalation. It should be improved
thickened.
9. Administer IV fluids and with effective therapy.
Vital signs as follows: medication as ordered. 9. IV fluid therapy can be
Temp: 38.1
beneficial for clients
PR: 100 bpm with dehydration. Medications
 Educative
10. Teach parents and child such as bronchodilators and

(075) 600 - 1507

Bright future starts here San Vicente West, Urdaneta City, Pangasinan
ucu.edu.ph | ucu.collegeofhealthsciences@gmail.com
 URDANETA CITY
UNIVERSITY COLLEGE OF HEALTH SCIENCES
Owned and operated by the City Government of Urdaneta

RR: 24 cpm about medication inhaled corticosteroids may be

administration as ordered and prescribed.
BP: 85/65
how to manage method of
O2SAT: 99% in room 10. Promotes compliance in
administration;
air order to prevent an attack and
advise avoiding over-the-
maintain wellness.
counter drugs without
physician advice. Promotes 11. Increased WBC count
compliance in order to prevent indicates an infection.
an attack and
maintain wellness. 12. A chest x-ray provides
information regarding the
presence of infiltrates, lung
Interdependent/Collaborative inflation, or the presence of
 Assessment barotrauma.
11. Monitor WBCC, as indicated.
13. Precipitators of allergic type
12. Monitor chest x-ray results, as of respiratory reactions that can
indicated. trigger or excarbate onset of
 Therapeutic acute episode.
13. Keep environmental pollution
14. Offers support to families
to a minimum according to
with the child suffering from
individual situation.
asthma.
14. Provide contact with
15. Limits exposure to factors
community agencies for
that can trigger an attack.
information and support.
Offers support to families
with the child suffering from
asthma.
 Educative

(075) 600 - 1507

Bright future starts here San Vicente West, Urdaneta City, Pangasinan
ucu.edu.ph | ucu.collegeofhealthsciences@gmail.com
 URDANETA CITY
UNIVERSITY COLLEGE OF HEALTH SCIENCES
Owned and operated by the City Government of Urdaneta

15. Instruct parents to modify the

home environment to reduce
dust, exposure to pets and
indoor plants, foods (peanut,
egg), changing of filters. Limits
exposure to factors that can
trigger an attack.

Checked by: MRS. JOANN BANIAGO Date:

Clinical Instructor’s Name and Signature

(075) 600 - 1507

Bright future starts here San Vicente West, Urdaneta City, Pangasinan
ucu.edu.ph | ucu.collegeofhealthsciences@gmail.com
 URDANETA CITY
UNIVERSITY COLLEGE OF HEALTH SCIENCES
Owned and operated by the City Government of Urdaneta

FDAR
Name of Student: GALIT, SUFINA ANN ALZATE Year Level and Group: BSN-3 GROUP A

Affiliating Agency/Area: Month/Year of Exposure: NOVEMBER 2021

DATE/TIME FOCUS DATA/ACTION/RESPONSE

11-08-2021 Ineffective Airway Clearance D› Received patient accompanied by his mother with a chief complaint of coughing for two weeks. Patient is alert and cooperative
5:00 PM in minimal distress. Eyes are clear, nasal mucosa is boggy with clear discharge, and pharynx has moderate lymphoid hypertrophy.
Has multiple small lymph nodes palpable in his upper neck. Chest has an increased AP diameter and it is tympanitic to percussion.
Rhonchi and occasional wheezes are heard on auscultation, but no retractions. Heart is in a regular rhythm and no murmurs are
heard. Skin is dry, but not flaky, inflamed or thickened. Vital signs as follows: T: 38.1, PR: 100 bpm, RR: 24 cpm, B: 85/65 mmhg,
O2SAT: 99% in room air.

A› Assessed vital signs. Auscultated lungs for adventitious breath sounds. Monitored side effects of bronchodilator. Monitored
chest x-ray results, as indicated. Planned for periods of rest between activities of the patient. Assisted patient to a comfortable
position. Demonstrated the correct breathing and coughing pattern. Provided contact with community agencies for information
and support. Promotes comfort and safety. Obtained peak expiratory flow rate. Administered medication as ordered. Educated
patient about the medications. Instructed patient to avoid exposure to persons with respiratory infections. Health needs attended.

R› Has a normal respiratory rate and pattern. Endorsed for continuity of care.

Checked by: MRS. JOANN BANIAGO Date:

Clinical Instructor’s Name and Signature

(075) 600 - 1507

Bright future starts here San Vicente West, Urdaneta City, Pangasinan
ucu.edu.ph | ucu.collegeofhealthsciences@gmail.com